• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    Cadre Holdings Reports Third Quarter 2024 Financial Results

    11/6/24 4:15:00 PM ET
    $CDRE
    Industrial Specialties
    Health Care
    Get the next $CDRE alert in real time by email

    Favorable Market Trends Continue to Drive Strong Demand for Cadre's Mission Critical Safety Equipment

    Cadre Holdings, Inc. (NYSE:CDRE) ("Cadre" or "Company"), a global leader in the manufacturing and distribution of safety equipment and other related products for the law enforcement, first responder, military and nuclear markets, announced today its consolidated operating results for the three and nine months ended September 30, 2024.

    • Net sales of $109.4 million for the third quarter; net sales of $391.6 million for the nine months ended September 30, 2024.
    • Gross profit margin of 36.6% for the third quarter; gross profit margin of 39.9% for the nine months ended September 30, 2024.
    • Net income of $3.7 million, or $0.09 per diluted share, for the third quarter; net income of $23.2 million, or $0.58 per diluted share, for the nine months ended September 30, 2024.
    • Adjusted EBITDA of $13.5 million for the third quarter; Adjusted EBITDA of $66.3 million for the nine months ended September 30, 2024.
    • Adjusted EBITDA margin of 12.4% for the third quarter; Adjusted EBITDA margin of 16.9% for the nine months ended September 30, 2024.
    • Declared quarterly cash dividend of $0.0875 per share in October 2024.

    "During the third quarter we continued to see strong and recurring demand for Cadre's best-in-class, mission-critical safety equipment," said Warren Kanders, CEO and Chairman. "While events unrelated to business macros have impacted our short-term financial performance, we've been pleased with the teams' overall progress and execution leveraging the Cadre operating model to drive constant organizational improvement and create greater value for customers and shareholders. Cadre continues to benefit from an innovative product offering, premium brands, and leading positions across our law enforcement, first responder, military and nuclear markets, supported by outstanding leadership."

    Mr. Kanders added, "Cadre's resilience through cycles is a primary strength of our business, highlighted by the Company's track record of consistent and stable growth regardless of economic, political or geopolitical conditions. We remain focused on taking advantage of the favorable industry trends fueling strong global demand for our highly engineered safety products. With a robust M&A pipeline, we continue to diligently evaluate potential transactions to add complementary businesses with strong margins, leading and defensible market positions, and recurring revenue profiles. We are confident in Cadre's forward outlook and believe we are ideally positioned to further expand our platforms and enhance our market leadership positions."

    Third Quarter and Nine-Month 2024 Operating Results

    For the quarter ended September 30, 2024, Cadre generated net sales of $109.4 million, as compared to $125.1 million for the quarter ended September 30, 2023. This was primarily a result of the cybersecurity incident that Cadre reported in July 2024 and a subsequent, negligible cybersecurity incident that occurred in September 2024. Each of these incidents led the Company to take certain containment and mitigation measures out of an abundance of caution, resulting in temporary interruptions or disruptions of normal business operations for select business units, which temporarily impacted the Company's production and order fulfillment activities.

    For the nine months ended September 30, 2024, Cadre generated net sales of $391.6 million, as compared to $357.9 million for the nine months ended September 30, 2023, primarily as a result of recent acquisitions and higher demand for armor and duty gear products, partially offset by the cybersecurity incidents.

    For the quarter ended September 30, 2024, Cadre generated gross profit of $40.0 million, as compared to $53.6 million for the quarter ended September 30, 2023. For the nine months ended September 30, 2024, Cadre generated gross profit of $156.3 million, as compared to $151.0 million for the prior year period.

    Gross profit margin was 36.6% for the quarter ended September 30, 2024, as compared to 42.8% for the quarter ended September 30, 2023, mainly driven by lower productivity in the Product segment due to the cybersecurity incidents and the amortization of inventory step up adjustments related to 2024 acquisitions, as well as unfavorable mix in the Distribution segment. Gross profit margin was 39.9% for the nine months ended September 30, 2024, as compared to 42.2% for the prior year period.

    Net income was $3.7 million for the quarter ended September 30, 2024, as compared to net income of $11.1 million for the quarter ended September 30, 2023. The decrease resulted primarily from reduced gross profit driven by lower productivity and lower revenue due to the cybersecurity incidents.

    Net income was $23.2 million for the nine months ended September 30, 2024, as compared to net income of $29.0 million for the prior year period, primarily as a result of an increase in gross profit driven by recent acquisitions, offset by an increase in selling, general and administrative expenses.

    Cadre generated $13.5 million of Adjusted EBITDA for the quarter ended September 30, 2024, as compared to $23.7 million for the quarter ended September 30, 2023. Adjusted EBITDA margin was 12.4% for the quarter ended September 30, 2024, as compared to 19.0% for the prior year period.

    Cadre generated $66.3 million of Adjusted EBITDA for the nine months ended September 30, 2024, as compared to $65.1 million for the prior period. Adjusted EBITDA margin was 16.9% for the nine months ended September 30, 2023, as compared to 18.2% for the prior year period.

    Product segment gross margin was 37.4% and 40.7% for the third quarter and first nine months of 2024, respectively, compared to 44.3% and 43.9% for the prior year periods.

    Distribution segment gross margin was 21.9% and 22.9% for the third quarter and first nine months of 2024, respectively, compared to 22.7% and 23.3% for the prior year periods.

    Liquidity, Cash Flows and Capital Allocation

    • Cash and cash equivalents increased by $5.3 million from $87.7 million as of December 31, 2023 to $93.0 million as of September 30, 2024.
    • Total debt increased by $68.0 million from $140.1 million as of December 31, 2023 to $208.1 million as of September 30, 2024.
    • Net debt (total debt net of cash and cash equivalents) increased by $62.7 million from $52.4 million as of December 31, 2023 to $115.1 million as of September 30, 2024.
    • Capital expenditures totaled $1.1 million for the third quarter and $4.5 million for the nine months ended September 30, 2024, compared with $1.8 million for the third quarter and $4.3 million for the nine months ended September 30, 2023.

    Dividend

    On October 22, 2024, the Company announced that its Board of Directors declared a quarterly cash dividend of $0.0875 per share, or $0.35 per share on an annualized basis. Cadre's dividend payment will be made on November 15, 2024 to shareholders of record as of the close of business on the record date of November 1, 2024. The declaration of any future dividend is subject to the discretion of the Company's Board of Directors.

    2024 Outlook

    Following the July cybersecurity incident and subsequent incident that occurred in September 2024, Cadre has implemented a number of countermeasures to improve the Company's infrastructure and will continue implementing additional countermeasures to protect its systems and data. Cadre has engaged a number of outside experts to assist in this effort. The Company believes it has contained the threat posed by the cybersecurity incidents and their associated risks and has resumed all affected business operations. The incidents caused Cadre to limit production to a greater extent than was originally forecasted in a number of its facilities during the investigation and remediation periods. As a result, the Company has modified its full year guidance for 2024 and now expects to generate net sales in the range of $560 million to $571 million and Adjusted EBITDA in the range of $101 million and $107 million. We expect capital expenditures to be in the range of $6 million to $8 million.

    Conference Call

    Management will host a conference call on Wednesday, November 6, 2024, at 5:00 p.m. EST to discuss the latest corporate developments and financial results. The dial-in number for callers in the US is (800)-715-9871 and the dial-in number for international callers is 646-307-1963. The access code for all callers is 3272793. A live webcast will also be available on the Company's website at https://www.cadre-holdings.com/.

    A replay of the call will be available through November 20, 2024. To access the replay, please dial 800-770-2030 in the U.S. or +1-609-800-9909 if outside the U.S., and then enter the access code 3272793.

    About Cadre

    Headquartered in Jacksonville, Florida, Cadre is a global leader in the manufacturing and distribution of safety products. Cadre's equipment provides critical protection to allow users to safely and securely perform their duties and protect those around them in hazardous or life-threatening situations. The Company's core products include body armor, explosive ordnance disposal equipment, duty gear and nuclear safety products. Our highly engineered products are utilized in over 100 countries by federal, state and local law enforcement, fire and rescue professionals, explosive ordnance disposal teams, and emergency medical technicians. Our key brands include Safariland® and Med-Eng®, amongst others.

    Use of Non-GAAP Measures

    The Company reports its financial results in accordance with U.S. generally accepted accounting principles ("GAAP"). The press release contains the non-GAAP measures: (i) earnings before interest, taxes, other income or expense, depreciation and amortization ("EBITDA"), (ii) adjusted EBITDA, (iii) adjusted EBITDA margin and (iv) last twelve months adjusted EBITDA. The Company believes the presentation of these non-GAAP measures provides useful information for the understanding of its ongoing operations and enables investors to focus on period- over-period operating performance, and thereby enhances the user's overall understanding of the Company's current financial performance relative to past performance and provides, along with the nearest GAAP measures, a baseline for modeling future earnings expectations. Non-GAAP measures are reconciled to comparable GAAP financial measures within this press release. We do not provide a reconciliation of the non-GAAP guidance measure Adjusted EBITDA for the fiscal year 2024 to net income for the fiscal year 2024, the most comparable GAAP financial measure, due to the inherent difficulty of forecasting certain types of expenses and gains, without unreasonable effort, which affect net income but not Adjusted EBITDA. The Company cautions that non-GAAP measures should be considered in addition to, but not as a substitute for, the Company's reported GAAP results. Additionally, the Company notes that there can be no assurance that the above referenced non-GAAP financial measures are comparable to similarly titled financial measures used by other publicly traded companies.

    Forward-Looking Statements

    Please note that in this press release we may use words such as "appears," "anticipates," "believes," "plans," "expects," "intends," "future," and similar expressions which constitute forward-looking statements within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are made based on our expectations and beliefs concerning future events impacting the Company and therefore involve a number of risks and uncertainties. We caution that forward-looking statements are not guarantees and that actual results could differ materially from those expressed or implied in the forward-looking statements. Potential risks and uncertainties that could cause the actual results of operations or financial condition of the Company to differ materially from those expressed or implied by forward-looking statements in this press release, include, but are not limited to, potential legal, reputational, operational and financial effects on the Company resulting from the cybersecurity incident that the Company reported in July 2024 and/or future cybersecurity incidents on the Company's business, operations and financial results as well as the effectiveness of the Company's response and mitigation efforts to any such cybersecurity incidents, as well as those risks and uncertainties more fully described from time to time in the Company's public reports filed with the Securities and Exchange Commission, including under the section titled "Risk Factors" in the Company's Annual Report on Form 10-K, and/or Quarterly Reports on Form 10-Q, as well as in the Company's Current Reports on Form 8-K. All forward-looking statements included in this press release are based upon information available to the Company as of the date of this press release and speak only as of the date hereof. We assume no obligation to update any forward- looking statements to reflect events or circumstances after the date of this press release.

    CADRE HOLDINGS, INC.

    CONDENSED CONSOLIDATED BALANCE SHEETS

    (Unaudited)

    (In thousands, except share and per share amounts)

     

     

     

     

     

     

     

     

     

    September 30, 2024

     

    December 31, 2023

    Assets

     

     

     

     

     

     

    Current assets

     

     

     

     

     

     

    Cash and cash equivalents

     

    $

    92,989

     

     

    $

    87,691

     

    Accounts receivable, net of allowance for doubtful accounts of $1,317 and $635, respectively

     

     

    69,432

     

     

     

    58,360

     

    Inventories

     

     

    99,583

     

     

     

    80,976

     

    Prepaid expenses

     

     

    15,603

     

     

     

    11,930

     

    Other current assets

     

     

    8,305

     

     

     

    6,886

     

    Total current assets

     

     

    285,912

     

     

     

    245,843

     

    Property and equipment, net of accumulated depreciation and amortization of $53,098 and $50,968, respectively

     

     

    46,221

     

     

     

    44,647

     

    Operating lease assets

     

     

    16,922

     

     

     

    6,554

     

    Deferred tax assets, net

     

     

    3,870

     

     

     

    4,004

     

    Intangible assets, net

     

     

    111,024

     

     

     

    43,472

     

    Goodwill

     

     

    148,944

     

     

     

    81,667

     

    Other assets

     

     

    3,722

     

     

     

    4,992

     

    Total assets

     

    $

    616,615

     

     

    $

    431,179

     

     

     

     

     

     

     

     

    Liabilities, Mezzanine Equity and Shareholders' Equity

     

     

     

     

     

     

    Current liabilities

     

     

     

     

     

     

    Accounts payable

     

    $

    27,565

     

     

    $

    28,418

     

    Accrued liabilities

     

     

    47,241

     

     

     

    44,524

     

    Income tax payable

     

     

    7,141

     

     

     

    9,944

     

    Current portion of long-term debt

     

     

    13,134

     

     

     

    12,320

     

    Total current liabilities

     

     

    95,081

     

     

     

    95,206

     

    Long-term debt

     

     

    194,949

     

     

     

    127,812

     

    Long-term operating lease liabilities

     

     

    12,032

     

     

     

    3,186

     

    Deferred tax liabilities

     

     

    8,782

     

     

     

    4,843

     

    Other liabilities

     

     

    5,490

     

     

     

    2,970

     

    Total liabilities

     

     

    316,334

     

     

     

    234,017

     

     

     

     

     

     

     

     

    Mezzanine equity

     

     

     

     

     

     

    Preferred stock ($0.0001 par value, 10,000,000 shares authorized, no shares issued and outstanding as of September 30, 2024 and December 31, 2023)

     

     

    —

     

     

     

    —

     

     

     

     

     

     

     

     

    Shareholders' equity

     

     

     

     

     

     

    Common stock ($0.0001 par value, 190,000,000 shares authorized, 40,607,988 and 37,587,436 shares issued and outstanding as of September 30, 2024 and December 31, 2023, respectively)

     

     

    4

     

     

     

    4

     

    Additional paid-in capital

     

     

    304,707

     

     

     

    212,630

     

    Accumulated other comprehensive (loss) income

     

     

    (1,079

    )

     

     

    634

     

    Accumulated deficit

     

     

    (3,351

    )

     

     

    (16,106

    )

    Total shareholders' equity

     

     

    300,281

     

     

     

    197,162

     

    Total liabilities, mezzanine equity and shareholders' equity

     

    $

    616,615

     

     

    $

    431,179

     

    CADRE HOLDINGS, INC.

    CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

    (Unaudited)

    (In thousands, except share and per share amounts)

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Three Months Ended September 30,

     

    Nine Months Ended September 30,

     

     

    2024

     

     

    2023

     

     

    2024

     

     

    2023

     

    Net sales

     

    $

    109,408

     

     

    $

    125,114

     

     

    $

    391,577

     

     

    $

    357,949

     

    Cost of goods sold

     

     

    69,392

     

     

     

    71,511

     

     

     

    235,283

     

     

     

    206,981

     

    Gross profit

     

     

    40,016

     

     

     

    53,603

     

     

     

    156,294

     

     

     

    150,968

     

    Operating expenses

     

     

     

     

     

     

     

     

     

     

     

     

    Selling, general and administrative

     

     

    33,981

     

     

     

    36,314

     

     

     

    113,277

     

     

     

    105,615

     

    Restructuring and transaction costs

     

     

    515

     

     

     

    439

     

     

     

    3,621

     

     

     

    1,132

     

    Related party expense

     

     

    94

     

     

     

    116

     

     

     

    2,038

     

     

     

    379

     

    Total operating expenses

     

     

    34,590

     

     

     

    36,869

     

     

     

    118,936

     

     

     

    107,126

     

    Operating income

     

     

    5,426

     

     

     

    16,734

     

     

     

    37,358

     

     

     

    43,842

     

    Other expense

     

     

     

     

     

     

     

     

     

     

     

     

    Interest expense

     

     

    (1,991

    )

     

     

    (1,073

    )

     

     

    (5,631

    )

     

     

    (3,727

    )

    Other income (expense), net

     

     

    1,555

     

     

     

    (315

    )

     

     

    (225

    )

     

     

    395

     

    Total other expense, net

     

     

    (436

    )

     

     

    (1,388

    )

     

     

    (5,856

    )

     

     

    (3,332

    )

    Income before provision for income taxes

     

     

    4,990

     

     

     

    15,346

     

     

     

    31,502

     

     

     

    40,510

     

    Provision for income taxes

     

     

    (1,335

    )

     

     

    (4,293

    )

     

     

    (8,352

    )

     

     

    (11,463

    )

    Net income

     

    $

    3,655

     

     

    $

    11,053

     

     

    $

    23,150

     

     

    $

    29,047

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Net income per share:

     

     

     

     

     

     

     

     

     

     

     

     

    Basic

     

    $

    0.09

     

     

    $

    0.29

     

     

    $

    0.58

     

     

    $

    0.77

     

    Diluted

     

    $

    0.09

     

     

    $

    0.29

     

     

    $

    0.58

     

     

    $

    0.77

     

    Weighted average shares outstanding:

     

     

     

     

     

     

     

     

     

     

     

     

    Basic

     

     

    40,607,988

     

     

     

    37,586,031

     

     

     

    39,723,702

     

     

     

    37,515,976

     

    Diluted

     

     

    40,949,461

     

     

     

    37,930,888

     

     

     

    40,118,729

     

     

     

    37,830,790

     

    CADRE HOLDINGS, INC.

    CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

    (Unaudited)

    (In thousands)

     

     

     

     

     

     

     

     

     

    Nine Months Ended September 30,

     

     

    2024

     

     

    2023

     

    Cash Flows From Operating Activities:

     

     

     

     

     

     

    Net income

     

    $

    23,150

     

     

    $

    29,047

     

    Adjustments to reconcile net income to net cash provided by operating activities:

     

     

     

     

     

     

    Depreciation and amortization

     

     

    12,325

     

     

     

    12,385

     

    Amortization of original issue discount and debt issue costs

     

     

    787

     

     

     

    359

     

    Amortization of inventory step-up

     

     

    3,851

     

     

     

    —

     

    Deferred income taxes

     

     

    (11,627

    )

     

     

    1,317

     

    Stock-based compensation

     

     

    6,255

     

     

     

    7,060

     

    Remeasurement of contingent consideration

     

     

    685

     

     

     

    —

     

    Provision for losses on accounts receivable

     

     

    757

     

     

     

    37

     

    Foreign exchange gain

     

     

    (788

    )

     

     

    (243

    )

    Other loss (gain)

     

     

    355

     

     

     

    (394

    )

    Changes in operating assets and liabilities, net of impact of acquisitions:

     

     

     

     

     

     

    Accounts receivable

     

     

    162

     

     

     

    3,429

     

    Inventories

     

     

    (2,589

    )

     

     

    (12,229

    )

    Prepaid expenses and other assets

     

     

    (4,161

    )

     

     

    (3,131

    )

    Accounts payable and other liabilities

     

     

    (21,096

    )

     

     

    8,623

     

    Net cash provided by operating activities

     

     

    8,066

     

     

     

    46,260

     

    Cash Flows From Investing Activities:

     

     

     

     

     

     

    Purchase of property and equipment

     

     

    (4,381

    )

     

     

    (4,248

    )

    Proceeds from disposition of property and equipment

     

     

    74

     

     

     

    206

     

    Business acquisitions, net of cash acquired

     

     

    (141,813

    )

     

     

    —

     

    Net cash used in investing activities

     

     

    (146,120

    )

     

     

    (4,042

    )

    Cash Flows From Financing Activities:

     

     

     

     

     

     

    Proceeds from revolving credit facilities

     

     

    5,500

     

     

     

    —

     

    Principal payments on revolving credit facilities

     

     

    (5,500

    )

     

     

    —

     

    Proceeds from term loans

     

     

    80,000

     

     

     

    —

     

    Principal payments on term loans

     

     

    (9,562

    )

     

     

    (7,500

    )

    Proceeds from insurance premium financing

     

     

    —

     

     

     

    3,949

     

    Principal payments on insurance premium financing

     

     

    (2,187

    )

     

     

    (2,909

    )

    Payments for debt issuance costs

     

     

    (844

    )

     

     

    —

     

    Taxes paid in connection with employee stock transactions

     

     

    (5,311

    )

     

     

    (2,725

    )

    Proceeds from secondary offering, net of underwriter discounts

     

     

    91,776

     

     

     

    —

     

    Deferred offering costs

     

     

    (683

    )

     

     

    —

     

    Dividends distributed

     

     

    (10,395

    )

     

     

    (8,999

    )

    Other

     

     

    37

     

     

     

    —

     

    Net cash provided by (used in) financing activities

     

     

    142,831

     

     

     

    (18,184

    )

    Effect of foreign exchange rates on cash and cash equivalents

     

     

    521

     

     

     

    92

     

    Change in cash and cash equivalents

     

     

    5,298

     

     

     

    24,126

     

    Cash and cash equivalents, beginning of period

     

     

    87,691

     

     

     

    45,286

     

    Cash and cash equivalents, end of period

     

    $

    92,989

     

     

    $

    69,412

     

    Supplemental Disclosure of Cash Flows Information:

     

     

     

     

     

     

    Cash paid for income taxes, net

     

    $

    22,761

     

     

    $

    7,923

     

    Cash paid for interest

     

    $

    10,523

     

     

    $

    7,389

     

    Supplemental Disclosure of Non-Cash Investing and Financing Activities:

     

     

     

     

     

     

    Accruals and accounts payable for capital expenditures

     

    $

    112

     

     

    $

    24

     

    CADRE HOLDINGS, INC.

    SEGMENT INFORMATION

    (Unaudited)

    (In thousands)

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Three Months Ended September 30, 2024

     

     

     

     

     

     

     

     

    Reconciling

     

     

     

     

     

    Product

     

    Distribution

     

    Items(1)

     

    Total

    Net sales

     

    $

    96,493

     

    $

    17,836

     

    $

    (4,921

    )

     

    $

    109,408

    Cost of goods sold

     

     

    60,386

     

     

    13,936

     

     

    (4,930

    )

     

     

    69,392

    Gross profit

     

    $

    36,107

     

    $

    3,900

     

    $

    9

     

     

    $

    40,016

     

     

    Three Months Ended September 30, 2023

     

     

     

     

     

     

     

     

    Reconciling

     

     

     

     

     

    Product

     

    Distribution

     

    Items(1)

     

    Total

    Net sales

     

    $

    108,495

     

    $

    24,208

     

    $

    (7,589

    )

     

    $

    125,114

    Cost of goods sold

     

     

    60,380

     

     

    18,724

     

     

    (7,593

    )

     

     

    71,511

    Gross profit

     

    $

    48,115

     

    $

    5,484

     

    $

    4

     

     

    $

    53,603

     

     

    Nine Months Ended September 30, 2024

     

     

     

     

     

     

     

     

    Reconciling

     

     

     

     

     

    Product

     

    Distribution

     

    Items(1)

     

    Total

    Net sales

     

    $

    343,711

     

    $

    71,615

     

    $

    (23,749

    )

     

    $

    391,577

    Cost of goods sold

     

     

    203,771

     

    $

    55,216

     

    $

    (23,704

    )

     

     

    235,283

    Gross profit

     

    $

    139,940

     

    $

    16,399

     

    $

    (45

    )

     

    $

    156,294

     

     

    Nine Months Ended September 30, 2023

     

     

     

     

     

     

     

     

    Reconciling

     

     

     

     

     

    Product

     

    Distribution

     

    Items(1)

     

    Total

    Net sales

     

    $

    305,057

     

    $

    74,594

     

    $

    (21,702

    )

     

    $

    357,949

    Cost of goods sold

     

     

    171,204

     

     

    57,200

     

     

    (21,423

    )

     

     

    206,981

    Gross profit

     

    $

    133,853

     

    $

    17,394

     

    $

    (279

    )

     

    $

    150,968

    ____________________________

    (1)

    Reconciling items consist primarily of intercompany eliminations and items not directly attributable to operating segments.

    CADRE HOLDINGS, INC.

    RECONCILIATION OF GAAP TO NON-GAAP FINANCIAL MEASURES

    (Unaudited)

    (In thousands)

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Year ended

     

    Three Months Ended

     

    Nine Months Ended

     

    Last Twelve

     

     

    December 31,

     

    September 30,

     

    September 30,

     

    Months

     

     

    2023

     

     

    2024

     

     

    2023

     

    2024

     

    2023

     

     

    September 30, 2024

    Net income

     

    $

    38,641

     

     

    $

    3,655

     

     

    $

    11,053

     

    $

    23,150

     

    $

    29,047

     

     

    $

    32,744

     

    Add back:

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Depreciation and amortization

     

     

    15,737

     

     

     

    3,763

     

     

     

    4,165

     

     

    12,325

     

     

    12,385

     

     

     

    15,677

     

    Interest expense

     

     

    4,531

     

     

     

    1,991

     

     

     

    1,073

     

     

    5,631

     

     

    3,727

     

     

     

    6,435

     

    Provision for income taxes

     

     

    14,283

     

     

     

    1,335

     

     

     

    4,293

     

     

    8,352

     

     

    11,463

     

     

     

    11,172

     

    EBITDA

     

    $

    73,192

     

     

    $

    10,744

     

     

    $

    20,584

     

    $

    49,458

     

    $

    56,622

     

     

    $

    66,028

     

    Add back:

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Restructuring and transaction costs(1)

     

     

    3,192

     

     

     

    515

     

     

     

    439

     

     

    5,371

     

     

    1,132

     

     

     

    7,431

     

    Other general income(2)

     

     

    (92

    )

     

     

    —

     

     

     

    —

     

     

    —

     

     

    —

     

     

     

    (92

    )

    Other (income) expense, net(3)

     

     

    (936

    )

     

     

    (1,555

    )

     

     

    315

     

     

    225

     

     

    (395

    )

     

     

    (316

    )

    Stock-based compensation expense(4)

     

     

    9,368

     

     

     

    2,104

     

     

     

    2,208

     

     

    6,255

     

     

    7,060

     

     

     

    8,563

     

    Stock-based compensation payroll tax expense(5)

     

     

    234

     

     

     

    —

     

     

     

    —

     

     

    441

     

     

    220

     

     

     

    455

     

    LTIP bonus(6)

     

     

    860

     

     

     

    —

     

     

     

    185

     

     

    49

     

     

    489

     

     

     

    420

     

    Amortization of inventory step-up(7)

     

     

    —

     

     

     

    1,541

     

     

     

    —

     

     

    3,851

     

     

    —

     

     

     

    3,851

     

    Contingent consideration expense(8)

     

     

    —

     

     

     

    176

     

     

     

    —

     

     

    685

     

     

    —

     

     

     

    685

     

    Adjusted EBITDA

     

    $

    85,818

     

     

    $

    13,525

     

     

    $

    23,731

     

    $

    66,335

     

    $

    65,128

     

     

    $

    87,025

     

    Adjusted EBITDA margin(9)

    16.5

     

    %

     

    12.4

     

    %

     

    19.0

    %

     

    16.9

    %

    18.2

    %

     

    ____________________________

    (1)

    Reflects the "Restructuring and transaction costs" line item on our consolidated statement of operations, which primarily includes transaction costs composed of legal and consulting fees. In addition, this line item reflects a $1.0 million transaction fee payable to Kanders & Company, Inc. for services related to the acquisition of ICOR that was accrued for during the year ended December 31, 2023 and a $1.8 million transaction fee paid to Kanders & Company, Inc. for services related to the acquisition of Alpha Safety for the nine months ended September 30, 2024, which are included in related party expense in the Company's consolidated statements of operations. Kanders & Company, Inc. is a company controlled by Warren B. Kanders, our Chairman of the Board and Chief Executive Officer.

     

    (2)

    Reflects gains from long-lived asset sales.

     

    (3)

    Reflects the "Other income (expense), net" line item on our consolidated statements of operations and primarily includes gains and losses due to fluctuations in foreign currency exchange rates.

     

    (4)

    Reflects compensation expense related to equity and liability classified stock-based compensation plans.

     

    (5)

    Reflects payroll taxes associated with vested stock-based compensation awards.

     

    (6)

    Reflects the cost of a cash-based long-term incentive plan awarded to employees that vests over three years.

     

    (7)

    Reflects amortization expense related to the step-up inventory adjustment recorded as a result of our recent acquisitions.

     

    (8)

    Reflects contingent consideration expense related to the acquisition of ICOR.

     

    (9)

    Reflects Adjusted EBITDA / Net sales for the relevant periods.

     

    View source version on businesswire.com: https://www.businesswire.com/news/home/20241106263231/en/

    Get the next $CDRE alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $CDRE

    DatePrice TargetRatingAnalyst
    2/21/2024$32.00 → $38.00Buy
    ROTH MKM
    1/22/2024Outperform → Mkt Perform
    Raymond James
    9/6/2022$30.00Buy
    BofA Securities
    8/31/2022$32.00Buy
    Jefferies
    3/11/2022$25.00 → $27.00Outperform
    Raymond James
    11/29/2021$24.00Buy
    Lake Street
    11/29/2021$23.00Overweight
    Stephens
    11/29/2021$20.00Hold
    Stifel
    More analyst ratings

    $CDRE
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Cadre Holdings Reports First Quarter 2025 Financial Results

      Capitalizes on Continued Strong Demand for Mission Critical Safety Equipment Completes Acquisition of Multiple Leading Nuclear Brands, Expanding Geographic Footprint Increased Guidance Reflects Completed Acquisition and Reaffirmed Organic Growth Expectations 2025 Outlook: Net Sales of $618 to $648 Million and Adjusted EBITDA of $112 to $122 Million Cadre Holdings, Inc. (NYSE:CDRE) ("Cadre" or "Company"), a global leader in the manufacturing and distribution of safety equipment and other related products for the law enforcement, first responder, military and nuclear markets, announced today its consolidated operating results for the three months ended March 31, 2025. Net sales of $130.

      5/6/25 4:15:00 PM ET
      $CDRE
      Industrial Specialties
      Health Care
    • Cadre Holdings Announces First Quarter 2025 Earnings and Conference Call Information

      Cadre Holdings, Inc. (NYSE:CDRE) ("Cadre" or "the Company"), a global leader in the manufacturing and distribution of safety equipment and other related products for the law enforcement, first responder, military and nuclear markets, announced today that it plans to release financial results for the first quarter that ended on March 31, 2025, on Tuesday, May 6, 2025, after the close of market trading. The company has scheduled a conference call to discuss these results on Wednesday, May 7, 2025, at 10:00 a.m. ET. The conference call will feature remarks by Warren Kanders, CEO and Chairman of the Board; Brad Williams, President; and Blaine Browers, Chief Financial Officer. To participate in

      4/23/25 4:15:00 PM ET
      $CDRE
      Industrial Specialties
      Health Care
    • Cadre Holdings Declares Quarterly Dividend of $0.095 Per Share

      Cadre Holdings, Inc. (NYSE:CDRE) ("Cadre" or "the Company"), a global leader in the manufacturing and distribution of safety equipment and other related products for the law enforcement, first responder, military and nuclear markets, today announced that its Board of Directors has declared a quarterly cash dividend of $0.095 per share, or $0.38 per share on an annualized basis. Cadre's dividend payment will be made on May 16, 2025 to shareholders of record as of the close of business on the record date of May 2, 2025. The declaration of any future dividend is subject to the discretion of the Company's Board of Directors. About Cadre Headquartered in Jacksonville, Florida, Cadre is a globa

      4/22/25 4:16:00 PM ET
      $CDRE
      Industrial Specialties
      Health Care

    $CDRE
    SEC Filings

    See more
    • SEC Form 10-Q filed by Cadre Holdings Inc.

      10-Q - Cadre Holdings, Inc. (0001860543) (Filer)

      5/6/25 4:17:42 PM ET
      $CDRE
      Industrial Specialties
      Health Care
    • Cadre Holdings Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

      8-K - Cadre Holdings, Inc. (0001860543) (Filer)

      5/6/25 4:15:16 PM ET
      $CDRE
      Industrial Specialties
      Health Care
    • Amendment: SEC Form SCHEDULE 13G/A filed by Cadre Holdings Inc.

      SCHEDULE 13G/A - Cadre Holdings, Inc. (0001860543) (Subject)

      4/29/25 4:15:29 PM ET
      $CDRE
      Industrial Specialties
      Health Care

    $CDRE
    Leadership Updates

    Live Leadership Updates

    See more
    • Cadre Holdings Appoints Gianmaria Delzanno to its Board of Directors

      Cadre Holdings, Inc. (NYSE:CDRE) ("Cadre" or "the Company"), a global leader in the manufacturing and distribution of safety equipment and other related products for the law enforcement, first responder, military and nuclear markets, announced the appointment of Gianmaria Delzanno to its board of directors, effective as of January 13, 2025. Current Director Nicholas Sokolow, who joined the board of Cadre's predecessor in July of 2012, will retire from the Company's board, effective as of January 31, 2025. Upon Mr. Sokolow's departure, Mr. Delzanno will replace Mr. Sokolow as the lead independent director and will also serve as Chairman of the Nominating and Corporate Governance Committee as

      1/13/25 4:15:00 PM ET
      $CDRE
      Industrial Specialties
      Health Care
    • Cadre Holdings Appoints Deborah DeCotis to its Board of Directors

      Cadre Holdings, Inc. (NYSE:CDRE) ("Cadre" or "the Company"), a global leader in the manufacturing and distribution of safety and survivability equipment for first responders, announced the appointment of Deborah DeCotis to its board of directors, effective immediately. With Ms. DeCotis' appointment, the Board will expand to five directors, four of whom are independent. Ms. DeCotis will also serve on the Company's Compensation Committee. Ms. DeCotis has over 45 years of financial, advisory and business operations experience with a successful track record of leadership across multiple global institutions and industries. She currently serves as Advisory Director at Morgan Stanley & Co., Inc.

      4/12/22 8:30:00 AM ET
      $CDRE
      Industrial Specialties
      Health Care
    • ElectraMeccanica Appoints Automotive Veteran, William Quigley III, to Board of Directors

      VANCOUVER, British Columbia, April 07, 2022 (GLOBE NEWSWIRE) -- ElectraMeccanica Vehicles Corp. (NASDAQ:SOLO) ("ElectraMeccanica" or the "Company"), a designer and manufacturer of electric vehicles revolutionizing the urban driving experience, today announced the appointment of William (Bill) Quigley III to its Board of Directors. Mr. Quigley is an accomplished leader with a proven track record in large enterprises specific to the automotive industry. With 30 plus years in the industry, Bill's career has included the following key roles: Executive Vice President and Chief Financial Officer at Dana Holding Corporation, an automotive, commercial vehicle and off-highway driveline, sealing an

      4/7/22 8:05:00 AM ET
      $CDRE
      $SOLO
      Industrial Specialties
      Health Care
      Auto Manufacturing
      Consumer Discretionary

    $CDRE
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13G/A filed by Cadre Holdings Inc.

      SC 13G/A - Cadre Holdings, Inc. (0001860543) (Subject)

      11/12/24 9:50:14 AM ET
      $CDRE
      Industrial Specialties
      Health Care
    • SEC Form SC 13G filed by Cadre Holdings Inc.

      SC 13G - Cadre Holdings, Inc. (0001860543) (Subject)

      2/14/24 7:58:49 PM ET
      $CDRE
      Industrial Specialties
      Health Care
    • SEC Form SC 13G/A filed by Cadre Holdings Inc. (Amendment)

      SC 13G/A - Cadre Holdings, Inc. (0001860543) (Subject)

      2/12/24 4:15:31 PM ET
      $CDRE
      Industrial Specialties
      Health Care

    $CDRE
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Amendment: SEC Form 4 filed by CHIEF FINANCIAL OFFICER Browers Blaine

      4/A - Cadre Holdings, Inc. (0001860543) (Issuer)

      4/24/25 4:47:07 PM ET
      $CDRE
      Industrial Specialties
      Health Care
    • Amendment: SEC Form 4 filed by PRESIDENT Williams Brad

      4/A - Cadre Holdings, Inc. (0001860543) (Issuer)

      4/24/25 4:45:45 PM ET
      $CDRE
      Industrial Specialties
      Health Care
    • Amendment: SEC Form 4 filed by CEO AND CHAIRMAN Kanders Warren B

      4/A - Cadre Holdings, Inc. (0001860543) (Issuer)

      4/24/25 4:45:13 PM ET
      $CDRE
      Industrial Specialties
      Health Care

    $CDRE
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • ROTH MKM reiterated coverage on Cadre Holdings with a new price target

      ROTH MKM reiterated coverage of Cadre Holdings with a rating of Buy and set a new price target of $38.00 from $32.00 previously

      2/21/24 9:51:23 AM ET
      $CDRE
      Industrial Specialties
      Health Care
    • Cadre Holdings downgraded by Raymond James

      Raymond James downgraded Cadre Holdings from Outperform to Mkt Perform

      1/22/24 7:15:32 AM ET
      $CDRE
      Industrial Specialties
      Health Care
    • BofA Securities initiated coverage on Cadre Holdings with a new price target

      BofA Securities initiated coverage of Cadre Holdings with a rating of Buy and set a new price target of $30.00

      9/6/22 7:24:20 AM ET
      $CDRE
      Industrial Specialties
      Health Care

    $CDRE
    Financials

    Live finance-specific insights

    See more
    • Cadre Holdings Reports First Quarter 2025 Financial Results

      Capitalizes on Continued Strong Demand for Mission Critical Safety Equipment Completes Acquisition of Multiple Leading Nuclear Brands, Expanding Geographic Footprint Increased Guidance Reflects Completed Acquisition and Reaffirmed Organic Growth Expectations 2025 Outlook: Net Sales of $618 to $648 Million and Adjusted EBITDA of $112 to $122 Million Cadre Holdings, Inc. (NYSE:CDRE) ("Cadre" or "Company"), a global leader in the manufacturing and distribution of safety equipment and other related products for the law enforcement, first responder, military and nuclear markets, announced today its consolidated operating results for the three months ended March 31, 2025. Net sales of $130.

      5/6/25 4:15:00 PM ET
      $CDRE
      Industrial Specialties
      Health Care
    • Cadre Holdings Announces First Quarter 2025 Earnings and Conference Call Information

      Cadre Holdings, Inc. (NYSE:CDRE) ("Cadre" or "the Company"), a global leader in the manufacturing and distribution of safety equipment and other related products for the law enforcement, first responder, military and nuclear markets, announced today that it plans to release financial results for the first quarter that ended on March 31, 2025, on Tuesday, May 6, 2025, after the close of market trading. The company has scheduled a conference call to discuss these results on Wednesday, May 7, 2025, at 10:00 a.m. ET. The conference call will feature remarks by Warren Kanders, CEO and Chairman of the Board; Brad Williams, President; and Blaine Browers, Chief Financial Officer. To participate in

      4/23/25 4:15:00 PM ET
      $CDRE
      Industrial Specialties
      Health Care
    • Cadre Holdings Declares Quarterly Dividend of $0.095 Per Share

      Cadre Holdings, Inc. (NYSE:CDRE) ("Cadre" or "the Company"), a global leader in the manufacturing and distribution of safety equipment and other related products for the law enforcement, first responder, military and nuclear markets, today announced that its Board of Directors has declared a quarterly cash dividend of $0.095 per share, or $0.38 per share on an annualized basis. Cadre's dividend payment will be made on May 16, 2025 to shareholders of record as of the close of business on the record date of May 2, 2025. The declaration of any future dividend is subject to the discretion of the Company's Board of Directors. About Cadre Headquartered in Jacksonville, Florida, Cadre is a globa

      4/22/25 4:16:00 PM ET
      $CDRE
      Industrial Specialties
      Health Care